|

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

RECRUITINGSponsored by Wake Forest University Health Sciences
Actively Recruiting
SponsorWake Forest University Health Sciences
Started2001-05-21
Est. completion2026-06
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01890486

Summary

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion Criteria:

Participation in any other treatment research protocol

Conditions11

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaCancerChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaGerm Cell NeoplasmsHodgkin's DiseaseImmunodeficiency DiseasesMultiple MyelomaMyelodysplastic Syndromes

Locations1 site

Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157
David Hurd, MD336-716-2843dhurd@wakehealth.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.